{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-107404","form_type":"8-K","ticker":"HRTX","cik":"0000818033","company_name":"HERON THERAPEUTICS, INC. /DE/","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.442376+00:00","generated_at":"2026-05-17T15:02:11.860773+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Heron Therapeutics enters manufacturing/supply deal with Patheon, commits to 38,400 kg through 2026","bullets":["Framework Agreement with Patheon Austria GmbH & Co KG, a Thermo Fisher unit, for manufacturing and supply of products.","Heron commits to purchase 38,400 kg of Products through December 31, 2026.","Prior agreements terminated; obligations replaced under amended Manufacturing and Supply Agreement.","Patheon to continue stability studies and provide warehousing services for the Products."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-107404","json":"https://secwatch.observer/filing/0000950170-25-107404.json","markdown":"https://secwatch.observer/filing/0000950170-25-107404.md","text":"https://secwatch.observer/filing/0000950170-25-107404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818033/000095017025107404/0000950170-25-107404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818033/000095017025107404/hrtx-20250806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:02:11.860773+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}